Voluntary Faculty
Voluntary faculty are typically clinicians or others who are employed outside of the School but make significant contributions to department programs at the medical center or at affiliate institutions.
Voluntary rank detailsRobert Morrison, MD
Clinical InstructorAbout
Research
Publications
2026
Maternal microchimerism at birth associates with reduced odds of non-malarial fever and respiratory tract infections in Tanzanian children
Petersen G, Edlefsen P, Li X, Morrison R, Kabyemela E, Nelson J, Duffy P, Fried M, Harrington W. Maternal microchimerism at birth associates with reduced odds of non-malarial fever and respiratory tract infections in Tanzanian children. PLOS Global Public Health 2026, 6: e0006439. PMID: 42127031, PMCID: PMC13170846, DOI: 10.1371/journal.pgph.0006439.Peer-Reviewed Original ResearchAntibody levels to variant and conserved Plasmodium falciparum antigens predict reduction in parasite burden in Malian children
Damena D, Dang L, Barry A, Renn J, Gaoussou S, Mahamar A, Attaher O, Issiaka D, Morrison R, Misal S, Dicko A, Duffy P, Fried M. Antibody levels to variant and conserved Plasmodium falciparum antigens predict reduction in parasite burden in Malian children. Frontiers In Immunology 2026, 16: 1745097. PMID: 41607793, PMCID: PMC12835252, DOI: 10.3389/fimmu.2025.1745097.Peer-Reviewed Original ResearchEpitope-specific competitive ELISA predicts malaria transmission-blocking vaccine Pfs230D1 activity measured in standard membrane feeding assay
Meehan C, Cowles M, Morrison R, Yi Y, Gu J, Hume J, Peyton M, Sagara I, Healy S, Renn J, Duffy P. Epitope-specific competitive ELISA predicts malaria transmission-blocking vaccine Pfs230D1 activity measured in standard membrane feeding assay. JCI Insight 2026, 11: e198414. PMID: 41477759, PMCID: PMC12892893, DOI: 10.1172/jci.insight.198414.Peer-Reviewed Original Research
2025
Transcript-Capture sequencing enriches mRNA of Mycobacterium tuberculosis from host samples
Lamont E, Jones R, Assadi J, Morrison R, Song T, Yu X, Weiner D, Via L, Winter J, Ma S, Wilkinson R, Barry C, Sherman D. Transcript-Capture sequencing enriches mRNA of Mycobacterium tuberculosis from host samples. NAR Molecular Medicine 2025, 3: ugaf045. PMID: 41522880, PMCID: PMC12783040, DOI: 10.1093/narmme/ugaf045.Peer-Reviewed Original ResearchIdentification of Plasmodium falciparum VAR2CSA peptides differentially recognized by IgG of multigravidae through epitope excision
Misal S, Renn J, Morrison R, Cowles M, Mahamar A, Attaher O, Dicko A, Duffy P, Fried M. Identification of Plasmodium falciparum VAR2CSA peptides differentially recognized by IgG of multigravidae through epitope excision. Frontiers In Immunology 2025, 16: 1704346. PMID: 41293178, PMCID: PMC12641020, DOI: 10.3389/fimmu.2025.1704346.Peer-Reviewed Original ResearchQuantitative measures to assess the quality of cellular indexing of transcriptomes and epitopes by sequencing data
Sun J, Morrison R, Kim S, Yan K, Park H. Quantitative measures to assess the quality of cellular indexing of transcriptomes and epitopes by sequencing data. Frontiers In Bioinformatics 2025, 5: 1630161. PMID: 41048342, PMCID: PMC12488637, DOI: 10.3389/fbinf.2025.1630161.Peer-Reviewed Original ResearchA Vaccine to Block Plasmodium falciparum Transmission.
Healy S, Sagara I, Assadou M, Katile A, Kone M, Imeru A, Kwan J, Swihart B, Fintzi J, Potter G, Zeguimé A, Dolo A, Diarra B, Narum D, Rausch K, MacDonald N, Zhu D, Mohan R, Thera I, Morrison R, Zaidi I, Doritchamou J, Sylla D, Hume J, Coulibaly M, Morelle D, Lievens M, Doumbo O, Duffy P. A Vaccine to Block Plasmodium falciparum Transmission. NEJM Evidence 2025, 4: evidoa2400188. PMID: 40552966, DOI: 10.1056/evidoa2400188.Peer-Reviewed Original ResearchSARS-CoV-2 Receptor Binding Domain (RBD) Protein–Protein Conjugate Induces Similar or Better Antibody Responses as Spike mRNA in Rhesus Macaques
Scaria P, Rowe C, Kosik I, Hu Z, Renn J, Alani N, Kemanli P, Orr-Gonzalez S, Lambert L, Adeyemi K, Doritchamou J, Barnafo E, Rausch K, Muslinkina L, Morrison R, Todd J, Esposito D, Lees A, Yewdell J, Duffy P. SARS-CoV-2 Receptor Binding Domain (RBD) Protein–Protein Conjugate Induces Similar or Better Antibody Responses as Spike mRNA in Rhesus Macaques. Vaccines 2025, 13: 648. PMID: 40573979, PMCID: PMC12197534, DOI: 10.3390/vaccines13060648.Peer-Reviewed Original ResearchAssessing of Pfdhps Gene of Sulfadoxine after Five Years of Seasonal Malaria Chemoprevention Implementation at Two Rural Sites in Mali: The Quantitative Method
Maiga H, Morrison R, Sagara I, Hume J, Healy S, H. Assadou M, Katile A, Zeguime A, Neal J, Zaidi I, E. Duffy P. Assessing of Pfdhps Gene of Sulfadoxine after Five Years of Seasonal Malaria Chemoprevention Implementation at Two Rural Sites in Mali: The Quantitative Method. Fortune Journal Of Health Sciences 2025 DOI: 10.26502/fjhs.298.Peer-Reviewed Original Research
2024
Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trial
Davar D, Morrison R, Dzutsev A, Karunamurthy A, Chauvin J, Amatore F, Deutsch J, Neves R, Rodrigues R, McCulloch J, Wang H, Hartman D, Badger J, Fernandes M, Bai Y, Sun J, Cole A, Aggarwal P, Fang J, Deitrick C, Bao R, Duvvuri U, Sridharan S, Kim S, Choudry M, Holtzman M, Pingpank J, O’Toole J, DeBlasio R, Jin Y, Ding Q, Gao W, Groetsch C, Pagliano O, Rose A, Urban C, Singh J, Divarkar P, Mauro D, Bobilev D, Wooldridge J, Krieg A, Fury M, Whiteaker J, Zhao L, Paulovich A, Najjar Y, Luke J, Kirkwood J, Taube J, Park H, Trinchieri G, Zarour H. Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trial. Cancer Cell 2024, 42: 1898-1918.e12. PMID: 39486411, PMCID: PMC11560503, DOI: 10.1016/j.ccell.2024.10.007.Peer-Reviewed Original Research